The global allopurinol market represents a significant segment of the pharmaceutical API industry, driven by the rising prevalence of gout and hyperuricemia worldwide. According to market research, the global allopurinol market was valued at USD 0.7 Billion in 2024 and is projected to reach USD 1.3 Billion by 2031, growing at a compound annual growth rate of 9.60% during the forecast period. This growth trajectory underscores the importance of understanding the buyer landscape for pharmaceutical suppliers, exporters, and procurement professionals. India has emerged as a dominant force in allopurinol production and export, with 223+ registered manufacturers shipping to buyers across 102+ countries. The total export value from India alone stands…